Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain Eur J Haematol
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma Future Oncol
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin Cancer Cell
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experience Vox Sang
Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome Leukemia
The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP) Front Pediatr
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials Clin Cancer Res
Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas Front Oncol
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors Cancer Res Commun
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study Blood Cancer J